The culture broth of Daedalea dickinsii was found to predominantly contain the tyrosinase inhibitor, (2R)-6-hydroxy-2-hydroxymethyl-2-methyl-2H-chromene, daedalin A (1). Ongoing research into bioactive metabolites resulted in the identification of two new 2H-chromenes, 6-hydroxy-5,7-dimethoxy-2,2-dimethyl-2H-chromene (3) and 6-hydroxy-2-hydroxymethyl-5-methoxy-2-methyl-2H-chromene (4), together with 6-hydroxy-2,2-dimethyl-2H-chromene (2). Comparative studies of isolated compounds 1-4 and related compounds (AE)-1 and 1a-1c showed 1 to have the strongest tyrosinase inhibitory activity. These results suggest that the hydroxyl groups at positions 6 and 9 of 1 were important for the potent activity. A Lineweaver-Burk plot for a kinetic analysis indicates that 1 competed with L-tyrosine for tyrosinase. Compound 1 also suppressed melanogenesis in a human skin model (up to 49% at 2.8 mol/tissue application) without affecting the cell viability. Compounds 1, 1b and 1c also showed 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity comparable to that of -tocopherol.
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Tyrosinase is a copper-containing enzyme which catalyzes the oxidation of L-tyrosine and L-3,4-dihydroxyphenylalanine (L-dopa). 1) These oxidation reactions are necessary for melanocytes to synthesize melanin, the compound largely responsible for hair and skin color in mammals. However, an excessive accumulation of melanin in the epidermis causes abnormal hyperpigmentation of the skin such as freckles and lentigines.
2) There has therefore been considerable effort to find an effective tyrosinase inhibitor. Some tyrosinase inhibitors such as arbutin 3) and kojic acid 4) have been used as pharmaceutical constituents in order to prevent hyperpigmentation. We have recently isolated from a mycelial culture broth of the Polyporaceae fungus, Daedalea dickinsii, a tyrosinase inhibitor, (2R)-6-hydroxy-2-hydroxymethyl-2-methyl-2H-chromene (1) which we named as daedalin A.
5) Several bioactive 2H-chromenes have been isolated and shown to have antioxidant, antiviral, antifungal, cytotoxic and anti-inflammatory activities. [6] [7] [8] [9] [10] We have reported that the tyrosinase inhibitory activity of 1 was stronger than that of arbutin. Furthermore, 1 also showed potent antioxidant activity. It would therefore be of interest to study the inhibition of melanin synthesis by daedalin A.
An analysis of the mycelial culture broth of D. dickinsii by thin-layer chromatography revealed the presence of several compounds in the broth. Our interest in the analogs of 1 isolated from D. dickinsii led to the synthesis of several compounds, and we then studied the structure/activity relationship of 1 and the analog compounds. In comparative studies, the most potent tyrosinase inhibitory compound, 1, also inhibited melanin biosynthesis in human skin.
Materials and Methods
General. (R)-trolox, L-tyrosine, L-dopa, tyrosinase and arbutin were purchased from Sigma Chemical Co. (St. Louis, MO, USA). A threedimensional cultured human skin model, Melanoderm (MEL312B), was purchased from Kurabo Co. (Osaka, Japan). The growth medium for the human skin model was a long-life maintenance medium (LLMM), supplied with the MEL312B kit. Other chemicals were purchased from Wako Pure Chemical Industries (Osaka, Japan). Mycelia of D. dickinsii were induced from fruiting bodies collected in Nara, Japan, and have been deposited in the Riken Bioresource Center (deposit number JCM12697, Saitama, Japan).
Instruments.
Optical rotation values were measured with a JASCO DIP 1000 polarimeter, and mass spectra were measured by a JEOL JMS 700 mass spectrometer.
1 H-and 13 C-NMR spectra were recorded by a Bruker DRX 500 FT-NMR spectrometer, operated at 500.1 MHz for protons and at 125.1 MHz for carbons. TMS was used as the internal standard. IR spectra were taken with a JASCO FT-IR 480 Plus spectrometer.
Isolation of 2, 3 and 4. Daedalea dickinsii mycelia were cultured in a liquid broth (10 liters) containing glucose (3%), polypeptone (0.5%), y To whom correspondence should be addressed. Fax: +81-265-77-1629; E-mail: hirotam@shinshu-u.ac.jp Biosci. Biotechnol. Biochem., 73 (3), [627] [628] [629] [630] [631] [632] 2009 yeast extract (0.2%), potassium dihydrogenphosphate (0.1%) and magnesium sulfate (0.05%). After 40 d, the culture broth was filtered to provide broth and mycelia. The filtered broth was extracted with EtOAc, and the extract (5.8 g) was chromatographed on silica gel (Wakogel C300, 150 g) with EtOAc/hexane (450 ml each), using a 10% stepwise elution gradient.
The 30% EtOAc/hexane eluate (21.3 mg) was purified in a silica gel column (Wakogel C300, 4 g) with 10% (10 ml Â 5), 15% (10 ml Â 5) and 20% EtOAc/hexane (5 ml Â 10) giving 20 fractions. Fractions 14-16 were combined (7.7 mg) and purified by HPLC (ODS-UG-5 column, Nomura Chemical; flow rate, 2.0 ml/min; eluent, 60% methanol/water). The fraction which eluted at t R 12.1 min was collected to give 2 (3.2 mg) as a colorless oil. Fraction no. 6 (12.5 mg) was purified by HPLC (ODS-UG-5 column; flow rate, 2.0 ml/min; eluent, 50% methanol/water). The fraction that eluted at t R 19.8 min was collected to give 3 (4.3 mg) as a colorless oil.
6-Hydroxy-2,2-dimethyl-2H-chromene (2) . The spectral data for 2 are consistent with 6-hydroxy-2,2-dimethyl-2H-chromene which had previously been isolated from Aplidium californicum by Cotelle et al.
6)
6-Hydroxy-5,7-dimethoxy-2,2-dimethyl-2H-chromene (3). IR (KBr) max cm À1 : 3446, 1490, 1203, 912, 853; 1 H-and 13 C-NMR: see Table 1 .
The 50% EtOAc/hexane (853 mg) fraction was purified in a silica gel column (Wakogel C300, 35 g) with 15% (20 ml Â 10), 20% (20 ml Â 5), 25% (20 ml Â 5), 30% (20 ml Â 5) and 40% acetone/ hexane (20 ml Â 5), giving thirty fractions. Fractions 24-30 were combined (14.5 mg) and purified by HPLC (ODS-UG-5 column; flow rate, 2.0 ml/min; eluent, 30% methanol/water). The fraction that eluted at t R 15.6 min was collected and provided 4 (1.5 mg) as a colorless oil.
6-Hydroxy-2-hydroxymethyl-5-methoxy-2-methyl-2H-chromene (4). ½ 1 H-and 13 C-NMR: see Table 1 .
Synthesis of 1a, 1b, 1c and (AE)-1. (2R)-2-Hydroxymethyl-6-methoxy-2-methyl-2H-chromene (1a)
. 1a was synthesized from 1 as previously described.
5)
(2R)-6-Hydroxy-2-hydroxymethyl-2-methyl-chroman (1b). To a solution of 1 (21 mg, 0.11 mmol) in EtOH (5.0 ml) was added 10% palladium on carbon (0.1 mg, 0.01 mmol) under a H 2 atmosphere. The mixture was stirred for 8 h, filtered and then concentrated. The residue was purified by silica gel column chromatography (hexane: EtOAc = 1:1) to give 1b (21 mg, 0.11 mmol, 100%) as a colorless oil, ½ (AE)-1 was synthesized from 2,5-dihydroxybenzaldehyde as previously described.
11)
DPPH radical scavenging test. The DPPH radical scavenging activities were evaluated as previously described.
5)
Tyrosinase inhibitory test. The tyrosinase inhibitory activities were determined by using L-tyrosine or L-dopa as the substrate, essentially as previously described.
12) The tyrosinase inhibitory test using Ltyrosine as the substrate was conducted as follows: L-tyrosine (400 ml of 5 mM) and 1460 ml of a 50 mM phosphate buffer (pH 6.8) were mixed with 100 ml of a sample in dimethyl sulfoxide. After adding 40 ml of an aqueous solution of mushroom tyrosinase (1000 U/ml, Sigma Chemical Co.), the mixture was incubated at 37 C for 60 min, and then the absorbance at 475 nm was measured to estimate the activity. Tyrosinase inhibition was calculated as inhibition (%) ¼ 100 Â ðA À BÞ=A, where A is the absorbance of the control, and B is the difference in absorbance before and after incubating the test sample. The tyrosinase inhibitory test using L-dopa as the substrate was conducted as follows: L-dopa (400 ml of 5 mM) and 1480 ml of a 50 mM phosphate buffer (pH 6.8) were mixed with 100 ml of a sample in dimethyl sulfoxide. After adding 20 ml of an aqueous solution of mushroom tyrosinase (1000 U/ml), the mixture was incubated at 25 C for 30 min, and then the absorbance at 475 nm was measured to estimate the activity. Tyrosinase inhibition was calculated as inhibition (%) ¼ 100 Â ðA À BÞ=A, where A is the absorbance of the control, and B is the difference in absorbance before and after incubating the test sample. The extent of inhibition by the addition of the sample is expressed as the percentage necessary for 50% inhibition (IC 50 ). The Michaelis constant (K m ), maximum velocity (V max ) and inhibition constant (K i ) for tyrosinase were determined by LineweaverBurk plots, using various concentrations of L-tyrosine.
Melanogenesis inhibitory assay using a three-dimensional human skin model. The melanogenesis inhibitory assay using a three-dimensional human skin model was performed as previously described, with slight modifications.
13) The three-dimensional cultured human skin model was placed in 6-well plates and incubated with 5 ml of LLMM at 37 C under 5% CO 2 . An aqueous solution (70 ml) of a test sample was applied to the surface of the tissue. The tissue was incubated for 14 d, with LLMM being replaced by a fresh medium on alternate days. After cultivation, the tissue was washed twice with Dulbecco's phosphate-buffered saline (DPBS) to remove the aqueous contaminants, and the melanin content and viability of the tissue cells were measured. To measure the melanin content, the tissue cells were rendered soluble by incubating with 400 ml of aqueous 1 N NaOH at 80 C for 2 h. The solution was centrifuged at 1000 Â g for 10 min, filtered, and the absorption of the supernatant was determined at 470 nm. The melanin content of the solution was calculated by comparing with the absorbance of synthetic melanin. Cell viability of the human skin model was evaluated by an MTT assay. After cultivating for 14 d, the tissue was placed in a 24-well plate, 3 ml of an MTT solution (MTT diluted with LLMM at 1 mg/ml) was added to each well, and the tissue was incubated at 37 C under 5% CO 2 . After 3 h of incubation, the tissue was washed twice with DPBS. Two milliliters of the MTT extract, isopropyl alcohol containing 40 mM HCl, and 40 ml of sodium dodecyl sulfate were then added to each well, and the plate was gently shaken at room temperature for 2 h. The absorbance of the extract was measured at 570 nm.
Result and Discussion
Structure of the isolated compounds 2-4 Compound 2 was identified as 6-hydroxy-2,2-dimethyl-2H-chromene by comparing the spectral data for 2 with the reference data. 6) High-resolution EIMS of 3 showed a molecular ion peak at m=z 236.1047, consistent with the molecular formula C 13 H 16 O 4 (Calcd.: 236.1049). The 1 H-and 13 C-NMR spectra resembled those of 2. Comparison of the 1 H-and 13 C-NMR data for 3 and 2 revealed that 3 differed from 2 by the presence of two methoxy groups ( C 61.3, H 3.87, C 56.2, H 3.84). The positions of the methoxy groups at C-5 and C-7 were determined on the basis of NOESY and HMBC correlations (Fig. 1) . Thus, 3 was elucidated as 6-hydroxy-5,7-dimethoxy-2,2-dimethyl-2H-chromene.
High-resolution EIMS of 4 showed a molecular ion peak at m=z 222.0890, consistent with the molecular formula C 12 H 14 O 4 (Calcd.: 222.0892). The IR spectrum of 4 showed absorption bands for OH groups (3446 cm À1 ) and a benzene ring (867 cm À1 ). As shown in Table 1 , the 1 H-and 13 C-NMR data for 4 were similar to those for 1, except for the presence of a methoxy group ( C 62.3, H 3.81) at position 5. We thus concluded that 4 was 5-methoxy-daedalin A; this was substantiated by C-H correlations between the methoxy proton ( H 3.81) and C-5 ( C 142.9), and between C-5 and H-4 ( H 6.69) in the HMBC spectrum (Fig. 1) .
Tyrosinase inhibitory activities
As shown in Fig. 3 , a hydroxyl and carboxyl group of L-tyrosine could adopt conformations similar to that of the two hydroxyl groups of 1. Compound 1 potently suppressed the hydroxylation of L-tyrosine by tyrosinase at low concentrations, but did not suppress the oxidation of L-dopa by tyrosinase at a concentration of 800 mM. Based on these results, the tyrosinase inhibitory activity of 1 was probably caused by competitive inhibition with L-tyrosine. This was confirmed by Lineweaver-Burk plots, using L-tyrosine as a substrate for tyrosinase with 1 (Fig. 4) . Compound 1 at 50 mM and 100 mM exhibited the same V max value of 1:5 Â 10 À2 and K m values of 7:5 Â 10 À1 AE 4:6 Â 10 À2 (n ¼ 3) and 1:0 AE 4:2 Â 10
À2
(n ¼ 3) mM. Therefore, daedalin A was proved to be a competitive inhibitor of L-tyrosine hydroxylation by tyrosinase, with a K i value of 4:6 Â 10 AE 9:3 Â 10
The tyrosinase inhibitory activities of the isolated compounds (1-4) and synthesized compounds (1a-1c, and (AE)-1) are shown in Table 2 . Compound 1 inhibited the tyrosinase activity by up to 60.7% at 400 mM, whereas 6-methoxy-daedalin A (1a) and 9-deoxy-daedalin A (2) did not show activity at 400 mM. These results suggest that the hydroxyl groups at positions 6 and 9 might have played an important role in the tyrosinase inhibitory activity of chromans. Interestingly, a racemer of 1 ((AE)-1) had weaker activity (IC 50 , 289 mM) than 1 (IC 50 , 194 mM). These results also support the competitive inhibitory mechanism for 1 on tyrosinase which was elucidated by the kinetic study of 1 and L-tyrosine.
Yu has reported the tyrosinase inhibitory effect of (R)-trolox bearing methyls at positions 5, 7 and 8. 14) However, the activity was extremely weak (IC 50 , 6100 mM), about 30 times lower than that of 1. Compound 1c did not show any activity at 800 mM, whereas the activity of 1b was stronger (IC 50 , 345 mM) than that of arbutin. Structurally, 1b and 1c differ by the presence of methyl groups at positions 5, 7 and 8. In addition, 4, which has a methoxy group at position 5, did not show activity at a concentration of 400 mM, and 3, which was substituted with methoxy groups at position 5 and 7, did not show activity at 800 mM. Therefore, the tyrosinase inhibitory activities of the chroman analogs were substantially decreased by methyl and methoxy groups on the benzene ring, possibly due to restricted binding to the enzyme. A tyrosinase inhibitory test revealed compound 1 to show the strongest activity among our tested chroman analogs. 
DPPH radical scavenging activities
Daedalin A (1) showed potent free radical scavenging activity. 5) We compared the DPPH radical scavenging activity of 1 with that of related compounds. As shown in Table 3 , at 100 mM, all the tested compounds except 1a scavenged more than 50% of the DPPH radicals. Among the compounds, 1 (IC 50 , 16.9 mM), 1b (IC 50 , 17.8 mM) and 1c (IC 50 , 14.0 mM) showed strong activities, comparable to that of (R)-trolox (IC 50 , 13.9 mM) andtocopherol (IC 50 , 14.2 mM). However 1a, which lacked a phenolic hydroxyl group, showed no activity at 500 mM. Therefore, the phenolic hydroxyl group was essential for the antioxidant activity of our tested compounds.
Melanin is also biosynthesized by the auto-oxidative The optimum conformation of compound 1 was generated by using MM2 computations of the Chem 3D program. action of dopaquinone, following the oxidation of L-tyrosine to L-dopa and of L-dopa to dopaquinone by tyrosinase. 15) It has been reported that some antioxidants prevent melanogenesis. For example, Hayakawa et al. have reported that an oral intake of -tocopherol was an effective treatment for facial hyperpigmentation, 16) and Matsuda et al. have reported that an antioxidant extract from Myrica rubra inhibited melanin synthesis. 17) In addition to the tyrosinase inhibitory activity of 1, the antioxidant activity might enhance the inhibitory activity toward melanin synthesis.
Melanogenesis inhibitory activity of 1
We evaluated the melanogenesis inhibitory activity of 1 on a three-dimensional cultured human skin model composed of normal human melanocytes and keratinocytes, as well as human skin. As shown in Fig. 5A , after 14 d of incubation of the cultured human skin model with 1, the pigmentation of the model was dosedependently suppressed. Figure 5B demonstrates that melanin synthesis by the model was reduced to 72% AE 4:2 (n ¼ 3) and 49% AE 2:3 (n ¼ 3) by 1 at 1.4 and 2.8 mmol per well, respectively. In contrast, the inhibitory activity of arbutin was 67% AE 4:1 (n ¼ 3) at 2.8 mmol per well. The cell viability of the human skin model was determined by using an MTT assay. After 14 d incubation with 2.8 mmol of 1 per well, the cell viability did not change (102% AE 7:5, n ¼ 3). Thus, 1 inhibited melanin biosynthesis in the human skin model without affecting the cell viability.
Conclusion
This study shows that daedalin A had the most potent tyrosinase inhibitory activity of the compounds tested. An analysis of structure-activity relationships and Lineweaver-Burk plots confirmed that the tyrosinase inhibitory activity of daedalin A was due to competitive inhibition with L-tyrosine.
Furthermore, daedalin A inhibited the pigmentation of a three-dimensional cultured human skin model without affecting the cell viability. In the epidermis, dermal pigmentation appears after the synthesis of melanin in melanosomes and the transfer of melanin pigment to epidermal cells. Melanin transfer is mediated by the expression of protease-activated receptor 2 (PAR-2) in keratinocytes, but not in melanocytes. 18, 19) Paine et al. have reported that a soybean extract inhibited pigmentation in a three-dimensional cultured human skin model, although the extract did not show tyrosinase inhibitory activity, 20) indicating that the inhibition of pigmentation was caused by the inhibition of PAR-2 activation. Since daedalin A inhibited melanin synthesis as well as tyrosinase activity, its inhibitory effect on pigmentation was probably due to the direct inhibition of tyrosinase activity in melanocytes. In addition to the tyrosinase inhibitory activity, the antioxidant activity might also have contributed to the melanogenesis inhibitory effect of daedalin A.
Yoon et al. have reported the melanogenesis inhibitory test using a three-dimensional cultured human skin 22) and Sugimoto et al. have reported the inhibitory effect of -arbutin.
13) The melanogenesis inhibitory activity of daedalin A on the three-dimensional cultured human skin model was stronger than that of arbutin. Thus, daedalin A is likely to inhibit melanin synthesis in human skin and could be used as a pharmaceutical constituent for preventing dermal hyperpigmentation. 
